Weiguo Wan

1.3k total citations · 1 hit paper
35 papers, 887 citations indexed

About

Weiguo Wan is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Weiguo Wan has authored 35 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Weiguo Wan's work include Systemic Lupus Erythematosus Research (8 papers), Gout, Hyperuricemia, Uric Acid (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). Weiguo Wan is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Gout, Hyperuricemia, Uric Acid (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). Weiguo Wan collaborates with scholars based in China, United States and Czechia. Weiguo Wan's co-authors include Hejian Zou, Xiaoxia Zhu, Yu Xue, Yiyun Yu, Maigeng Zhou, Limin Wang, Mei Zhang, Zhenping Zhao, Yu Xue and Xiao Zhang and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Weiguo Wan

33 papers receiving 878 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19

2022 230 citations Mei Zhang, Xiaoxia Zhu et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiguo Wan China	16	313	267	254	236	178	35	887
Yeong‐Jian Jan Wu Taiwan	16	173 0.6×	279 1.0×	537 2.1×	173 0.7×	284 1.6×	38	970
Julia Weinmann‐Menke Germany	16	183 0.6×	437 1.6×	326 1.3×	201 0.9×	161 0.9×	101	1.1k
Gabriela Alperovich Spain	17	176 0.6×	220 0.8×	125 0.5×	233 1.0×	186 1.0×	35	925
Jeong Hae Kie South Korea	16	240 0.8×	155 0.6×	128 0.5×	181 0.8×	72 0.4×	56	788
Μaria Stangou Greece	17	506 1.6×	212 0.8×	177 0.7×	203 0.9×	61 0.3×	90	972
Masayuki Iyoda Japan	18	555 1.8×	313 1.2×	141 0.6×	278 1.2×	66 0.4×	69	1.2k
Huiping Chen China	20	466 1.5×	153 0.6×	207 0.8×	273 1.2×	117 0.7×	56	1.2k
Yuan Min Wang Australia	22	350 1.1×	685 2.6×	97 0.4×	273 1.2×	90 0.5×	45	1.3k
Annette J. Schlueter United States	20	59 0.2×	357 1.3×	167 0.7×	241 1.0×	116 0.7×	58	1.0k
Hang Li China	15	313 1.0×	109 0.4×	82 0.3×	149 0.6×	75 0.4×	67	736

Countries citing papers authored by Weiguo Wan

Since Specialization

Citations

This map shows the geographic impact of Weiguo Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Wan more than expected).

Fields of papers citing papers by Weiguo Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Wan. The network helps show where Weiguo Wan may publish in the future.

Co-authorship network of co-authors of Weiguo Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Wan. A scholar is included among the top collaborators of Weiguo Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Wan. Weiguo Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaoyun, et al.. (2025). Mitochondrial dysfunction in fibrotic diseases: Research progress and MSC-exos therapy. Experimental and Molecular Pathology. 143. 104983–104983.

Sun, Fangfang, Danting Zhang, Nan Shen, et al.. (2025). Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 85(3). 489–496.

Zhang, Fa‐Li, Yu Xiao, Yingyu Wang, et al.. (2024). Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts. Free Radical Biology and Medicine. 221. 23–30. 10 indexed citations

Leng, Xiaomei, Wei Lin, Shixue Liu, et al.. (2023). Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD Open. 9(1). e002559–e002559. 15 indexed citations

Zhao, Tianyi, Lin Cong, Xue Yang, et al.. (2023). Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack. Lara D. Veeken. 62(12). 3984–3992. 7 indexed citations

Zhao, Li, Tianyi Zhao, Xue Yang, et al.. (2022). IL-37 blocks gouty inflammation by shaping macrophages into a non-inflammatory phagocytic phenotype. Lara D. Veeken. 61(9). 3841–3853. 21 indexed citations

Zhang, Mei, Xiaoxia Zhu, Jing Wu, et al.. (2022). Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19. Frontiers in Immunology. 12. 791983–791983. 230 indexed citations breakdown →

Wang, Yingyu, et al.. (2022). The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis. Frontiers in Immunology. 13. 1015882–1015882. 29 indexed citations

Zhao, Tianyi, Yu Xue, Yueying Chen, et al.. (2022). The Anti-Inflammatory and Uric Acid Lowering Effects of Si-Miao-San on Gout. Frontiers in Immunology. 12. 777522–777522. 32 indexed citations

10.

Wu, Wanlong, Wenwen Xu, Wenjia Sun, et al.. (2021). Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. Lara D. Veeken. 61(1). 230–239. 39 indexed citations

11.

Zhang, Jing, Weiguo Wan, Liyan Miao, et al.. (2020). Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study. Rheumatology and Therapy. 7(1). 191–200. 4 indexed citations

12.

Sun, Fangfang, Shikai Geng, Xiaodong Wang, et al.. (2020). Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet Rheumatology. 2(4). e210–e216. 50 indexed citations

13.

Yu, Yiyun, Xianglin Zhang, Li Zhao, et al.. (2019). Leptin facilitates the differentiation of Th17 cells from MRL/Mp-Fas lpr lupus mice by activating NLRP3 inflammasome. Innate Immunity. 26(4). 294–300. 20 indexed citations

14.

Jiang, Li, Lei Liu, Xiangyü Li, et al.. (2017). New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions. Dermatology. 233(1). 37–46. 72 indexed citations

15.

Sun, Ying, Lili Ma, Lingying Ma, et al.. (2017). Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu’s arteritis. Rheumatology International. 37(12). 2019–2026. 28 indexed citations

16.

Zhu, Xiaoxia, Haiyan Chu, Shuai Jiang, et al.. (2017). Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway. Journal of Dermatological Science. 87(2). 149–158. 33 indexed citations

17.

Li, Jiang, et al.. (2016). Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy. Chinese Medical Journal. 129(3). 267–273. 20 indexed citations

18.

Zheng, Yonghua, et al.. (2015). Skin telocytes versus fibroblasts: two distinct dermal cell populations. Journal of Cellular and Molecular Medicine. 19(11). 2530–2539. 47 indexed citations

19.

Xue, Yu, Li Jiang, Haiyan Chen, et al.. (2012). Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions. PLoS ONE. 7(10). e46740–e46740. 80 indexed citations

20.

Zheng, Shucong, et al.. (2011). [Meta-analysis of the effectiveness of plasma exchange in treatment of severe and acute organophosphate poisoning].. PubMed. 29(10). 779–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact